Compelling evidence for SGLT2 inhibitors and GLP-1 receptor agonists as first-line therapy in patients with diabetes at very high/high cardiovascular risk
- PMID: 31800036
- DOI: 10.1093/eurheartj/ehz853
Compelling evidence for SGLT2 inhibitors and GLP-1 receptor agonists as first-line therapy in patients with diabetes at very high/high cardiovascular risk
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
